‘The NAD+ system is under daily attack – it needs boosting’

‘The NAD+ system is under daily attack – it needs boosting’

ChromaDex’s Dr Charles Brenner talks NAD+ and explains how Niagen enhances resilience against metabolic stress.

Yesterday, Longevity.Technology announced a new venture – the launch of its consumer products division, dedicated to science-backed longevity solutions. Our inaugural product, the Longevity.Technology LONGEVITY supplement, showcases a unique blend of evidence-based ingredients aimed at enhancing healthspan and cellular vitality.

A major highlight of this launch is the partnership with ChromaDex , a leader in NAD+ research, to feature Niagen – ChromaDex’s proprietary nicotinamide riboside (NR) – as the supplement’s “hero” ingredient. Niagen has been shown to boost NAD+ levels, essential for cellular and metabolic functions, marking a strong foundation for the supplement’s cellular health benefits.

My take on this: Collaborating with leading suppliers and backed by human trials, Longevity.Technology emphasizes transparency and efficacy. By partnering with ChromaDex, a company known for its dedication to scientific rigor, we are demonstrating a commitment to bringing only the most effective, high-quality products to market. We sat down with one of the foremost experts in NAD+ research, Dr Charles Brenner , who is ChromaDex Chief Scientific Advisor, to find out more about his discovery that nicotinamide riboside is a precursor for NAD+, how NR affects aging and cellular health and Niagen’s potential for improving healthspan.

Dr Charles Brenner on spreading the word

It’s key to talk to the public about how important NAD is, how NAD comes under attack in conditions of metabolic stress and that Niagen, the patented NR, is a safe way to boost NAD and be resilient to those conditions of metabolic stress.

Discover more insights from Dr Brenner by watching the full video HERE.

Thanks for reading! If you’ve enjoyed this article, it would mean a lot to me if you could subscribe and share it on LinkedIn!


Liliya Euro

Ph.D., Docent in Medical Molecular Biology, Senior Researcher at University of Helsinki, Chief Scientific Officer in NADMED Ltd, Co-Founder of NADMED Ltd

1 周

Supplementation is beneficial when it is needed and has to be followed up by measurement blood NAD+ levels. Blood NAD+ level is a reliable marker for body deficiency and increased need for NAD+ precursors. Dose of the supplement is a key parameter and has to be individual. A lot is not always better. We also have to remember that consumed precursors, intermediates of NAD synthesis are active molecules and increase of their concentrations can potentially lead to unwanted consequences.

Raymond D Palmer

Longevity Researcher / Biotech Engineer / mRNA Alchemist / Astronomer / PhD Candidate / Author Anti-Aging Toolkit

1 周

I like Brenner, he has an IQ and is an industry leader. However, I rarely see anyone in the industry talking about the negative side effects of elevated NAD levels. I was just messaging a colleage about this subject and felt this had to be posted. As far as I know, I beleive I am the only scientist that has written paper about the dangers of high NAD levels. I agree that higher levels are great for aging, but users need to take into account their family history, genetics and lifestyle, as NAD can speed up the progression of some diseases. My paper below -https://pubmed.ncbi.nlm.nih.gov/34964015/

Steven AR Murphy MD

Concierge Regenerative Medicine Specialist, Board Certified, Medical Educator, Laboratory and Medical Director at Concierge Medical Associates. Sex Medicine Expert.

1 周

I prefer support with 1 MNA

Iain De Havilland

Founder of NADclinic Group. The Leading Global Producer & Purveyor of Premium NAD+ Injectables & Therapeutics. Entrepreneur Passionate about Health, Wellness & Human Performance Innovation. GWI Ambassador. MBA Student

1 周

100% agree that our NAD+ system and NAD+ levels need to be boosted & elevated to ward off metabolic stress and to enhance cellular vitality & healthspan.

要查看或添加评论,请登录